There is no standard of care adjuvant therapy for cholangiocarcinoma. Many of us would feel BILCAP capecitabine did not show enough of the promised improved outcome we all were looking for; and thus many of us would default to gemcitabine plus cisplatin, based on read world data and experience. Many...